Salesforce (CRM) Stock Forecast & Price Target

$342.12 +6.34 (+1.89%)

(As of 11/22/2024 ET)

Salesforce - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 39 Analyst Ratings

Sell
0

Hold
8

Buy
31

Based on 39 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 39 analysts, 8 have given a hold rating, 27 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$336.37
-1.68% Downside

According to the 39 analysts' twelve-month price targets for Salesforce, the average price target is $336.37. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted downside of -1.68% from the current price of $342.12.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 11/24/23 to 11/23/24	1 Month Ago 10/25/23 to 10/24/24	3 Months Ago 8/26/23 to 8/25/24	1 Year Ago 11/24/22 to 11/24/23
Strong Buy	4 Strong Buy rating(s)	4 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	27 Buy rating(s)	25 Buy rating(s)	24 Buy rating(s)	25 Buy rating(s)
Hold	8 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	13 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$336.37	$312.51	$291.50	$243.39
Forecasted Upside	-1.68% Downside	8.99% Upside	10.42% Upside	8.47% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.90	2.67	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-1.68% Downside	540.86% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/22/2024	UBS Group 4 of 5 stars		Boost Target	Neutral ➝ Neutral	$275.00 ➝ $360.00	+5.26%
11/22/2024	JMP Securities 2 of 5 stars		Boost Target	Market Outperform ➝ Market Outperform	$342.00 ➝ $450.00	+33.85%
11/21/2024	TD Cowen 4 of 5 stars		Boost Target	Hold ➝ Hold	$290.00 ➝ $340.00	+0.01%
11/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$330.00 ➝ $385.00	+16.49%
11/20/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$310.00 ➝ $340.00	+5.17%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
11/18/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sector Outperform	$425.00	+31.89%
11/15/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$305.00 ➝ $385.00	+16.12%
11/14/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$270.00 ➝ $340.00	+1.92%
11/13/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$325.00 ➝ $390.00	+13.03%
11/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$275.00 ➝ $330.00	-4.35%
11/11/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$350.00 ➝ $400.00	+22.40%
10/28/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$320.00 ➝ $350.00	+18.41%
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/10/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
10/2/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$270.00 ➝ $400.00	+47.67%
9/27/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$315.00 ➝ $325.00	+17.67%
9/20/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$345.00 ➝ $345.00	+29.76%
9/19/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$300.00 ➝ $315.00	+17.01%
9/19/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+15.14%
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$234.00 ➝ $236.00	-8.87%
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$230.00 ➝ $250.00	-2.93%
8/29/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$300.00 ➝ $315.00	+22.31%
8/29/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$320.00 ➝ $330.00	+27.46%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$295.00 ➝ $315.00	+21.63%
8/26/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$260.00 ➝ $290.00	+8.59%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
5/31/2024	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$330.00 ➝ $275.00	+20.09%
5/30/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$355.00 ➝ $305.00	+40.88%
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$345.00 ➝ $300.00	+10.25%
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
3/21/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sector Weight
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
Let’s be blunt (Ad) Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now
10/2/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Conviction-Buy ➝ Buy
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%
6/1/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
6/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
3/2/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$140.00 ➝ $200.00	+19.51%
2/21/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$160.00 ➝ $170.00	+2.92%
1/20/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
12/5/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$250.00 ➝ $225.00	+55.64%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:10 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 6, 2024. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce's consistent dividend payouts provide a steady income stream for investors, with a current dividend yield of 0.56%.
Analysts have given Salesforce a positive outlook, with a majority of them rating the stock as a buy or strong buy, indicating confidence in the company's future performance.
Institutional investors, such as Vanguard Group Inc. and Capital Research Global Investors, have been increasing their stakes in Salesforce, signaling strong confidence in the company's growth potential.
Recent insider activity, including significant share sales by directors, may indicate that insiders believe the stock is currently overvalued, potentially prompting a correction in the stock price.
Despite a slight decrease in stock price on the trading day, Salesforce's overall performance has been positive, with the stock trading at $288.10, showing resilience in the market.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

The company's payout ratio of 28.78% indicates that a significant portion of its earnings is being distributed as dividends, potentially limiting funds available for reinvestment in growth initiatives.
While the majority of analysts have a positive outlook on Salesforce, there are still some hold ratings, suggesting a level of uncertainty or caution among a portion of analysts regarding the company's future performance.
Insider selling activity, with directors selling significant amounts of shares, may raise concerns about insider confidence in the company's long-term prospects.
Despite institutional investors increasing their stakes, the high percentage of institutional ownership at 80.43% may lead to increased volatility in the stock price due to large-scale buying or selling decisions by these entities.
Recent fluctuations in the stock price, including a decrease on the trading day, could indicate short-term market uncertainty or potential volatility in the near future.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 39 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $336.37, with a high forecast of $450.00 and a low forecast of $236.00.
: 39 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 8 hold ratings, 27 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted downside of -1.68% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 6 upgrades and 1 downgrade by analysts.
: Salesforce has been rated by research analysts at Bank of America, BMO Capital Markets, BNP Paribas, Canaccord Genuity Group, Cfra, Citigroup, DA Davidson, Erste Group Bank, Evercore ISI, FBN Securities, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., Loop Capital, Morgan Stanley, Needham & Company LLC, Northland Capmk, Northland Securities, Oppenheimer, Phillip Securities, Piper Sandler, Raymond James, Robert W. Baird, Roth Mkm, Royal Bank of Canada, Sanford C. Bernstein, Scotiabank, Stifel Nicolaus, TD Cowen, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.90 while the average consensus rating score for "computer and technology" companies is 2.67. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

This page (NYSE:CRM) was last updated on 11/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target